Evaluating the efficacy of accelerated iTBS in the management of neuropathic pain

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100054219

Enrollment

Unknown

Registered

2021-12-11

Start date

2021-12-08

Completion date

Unknown

Last updated

2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic neuropathic pain

Interventions

Standard group:10 Hz rTMS(repetitive Transcranial Magnetic Stimulation)

Accelerated iTBS (intermittent theta-burst stimulation) group:Accelerated iTBS

Control group:Sham stimualtion

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. IASP diagnosis of peripheral neuropathic pain; 2. rTMS illegible; 3. Aged >= 18 years; 4. Pain intensity between 3-9 assessed by VAS; 5. No changes in medication from 2 weeks before the allocation to the end of the trial; 6. Capable of fulfilling assessments.

Exclusion criteria

Exclusion criteria: 1. Not able to receive rTMS; 2. Severe mental disorders: HAMD >= 35 or HAMA >= 29; 3. Aphasia or cognitive disorders: MMSE 2; 6. Severe heart or lung misfunctioning or extremely weak.

Design outcomes

Primary

Measure	Time frame
Visual Analogue Scale;	—

Countries

China

Contacts

Public ContactChe Xianwei

The Affiliated Hospital of Hangzhou Normal University

xwcheswu@gmail.com+86 18072852895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026